I believe the member opposite is talking about the drug Trikafta, and many cystic fibrosis patient groups have been advocating having access to it in Canada. In fact, the manufacturer of Trikafta has not submitted an application to market this product in Canada.
However, that said, we do have a special access program for drugs that are not marketed in Canada. As of May 6, Health Canada approved 95 applications for 98 patients to access Trikafta through the special access program. I would encourage all patients with cystic fibrosis to speak to their doctor to ensure that they too can apply through the special access program.